Company
Maxigen Biotech
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
5
510(k), De Novo and PMA
Device trials
10
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
Recall records
0
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Maxigen Biotech, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Maxigen Biotech.
Latest FDA decisions
K260483 · Decided Nov 4, 2026 · 264 days after receipt
Device type: Barrier, Animal Source, Intraoral (NPL) · Dentistry & Oral Surgery
K253989 · Decided Sep 3, 2026 · 265 days after receipt
Device type: Lubricant, Personal (NUC) · Obstetrics & Gynecology
K242100 · Decided Oct 16, 2025 · 455 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
2 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Efficacy and Safety of NasoAid® After Nasal SurgeryPivotal-lookingRecruiting
NCT07861061 · 154 participants (planned) · Start Aug 24, 2026 · Primary completion Apr 30, 2027
Device: NasoAid® Intranasal Splint; "Stryker" NasoPore Nasal Dressing · For: Nasal Surgery; Hemostasis; Nasal Packing
Sites: Taipei, Taiwan; Taoyuan, Taiwan · 3 sites in all
NCT07209020 · 60 participants (planned) · Start May 20, 2025 · Primary completion Oct 31, 2025
Device: HealiAid Collagen Wound Dressing · For: Breast Tumors; Wound Healing; Collagen Wound Dressing
Sites: New Taipei City, Taiwan; Taipei, Taiwan · 3 sites in all
- ArtiBest for Knee OsteoarthritisRecruiting
NCT06994546 · 60 participants (planned) · Start Mar 11, 2025 · Primary completion Nov 30, 2025
Device: ArtiBest ® Intra articular Injection · For: Knee Osteoarthristis
Sites: Kaohsiung City, Taiwan
7 more trials with a free account
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls under this name in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.